Results 21 to 30 of about 5,926,327 (233)

Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review. [PDF]

open access: yesFront Pharmacol, 2021
Fusidic acid (FA) is a natural tetracyclic triterpene isolated from fungi, which is clinically used for systemic and local staphylococcal infections, including methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections ...
Long J, Ji W, Zhang D, Zhu Y, Bi Y.
europepmc   +2 more sources

Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of Staphylococcus aureus, Belgium, 2013 to 2023. [PDF]

open access: yesEuro Surveill
Background Antimicrobial resistance to mupirocin and fusidic acid, which are used for treatment of skin infections caused by Staphylococcus aureus, is of concern.
Yin N   +8 more
europepmc   +2 more sources

Curcumin/Fusidic Acid Bitherapy Loaded Mixed Micellar Nanogel for Acne Vulgaris Treatment: In Vitro and In Vivo Studies

open access: yesAAPS PharmSciTech, 2023
The combination of herbal drugs with a topical antibacterial for managing a chronic disease like acne vulgaris has emerged lately to settle side effects and bacterial multidrug resistance.
Raghda Abdel-monem   +3 more
semanticscholar   +1 more source

Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile. [PDF]

open access: yesACS Infect Dis, 2021
Fusidic acid (FA) is a potent steroidal antibiotic that has been used in Europe for more than 60 years to treat a variety of infections caused by Gram-positive pathogens. Despite its clinical success, FA requires significantly elevated dosing (3 g on the
Garcia Chavez M   +6 more
europepmc   +2 more sources

Characterization of two malaria parasite organelle translation elongation factor G proteins: the likely targets of the anti-malarial fusidic acid. [PDF]

open access: yesPLoS ONE, 2011
Malaria parasites harbour two organelles with bacteria-like metabolic processes that are the targets of many anti-bacterial drugs. One such drug is fusidic acid, which inhibits the translation component elongation factor G. The response of P.
Russell A Johnson   +2 more
doaj   +1 more source

STUDY OF ANTIMICROBIAL ACTIVITY OF "FUZIPAN-DERMA" GEL [PDF]

open access: yesAnnals of Mechnikov's Institute, 2018
Introduction. Providing the population with effective drugs for the treatment of infectious diseases of the skin has an important medical and socio-economic significance.
Bayva P. P.   +3 more
doaj   +1 more source

Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma [PDF]

open access: yes, 2015
OBJECTIVES: Increasing multidrug resistance amongst canine pathogenic staphylococci has renewed interest in topical antibacterial therapy for skin infections in the context of responsible veterinary prescribing.
A. Loeffler   +8 more
core   +2 more sources

Characterisation of S. aureus/MRSA CC1153 and review of mobile genetic elements carrying the fusidic acid resistance gene fusC

open access: yesScientific Reports, 2021
While many data on molecular epidemiology of MRSA are available for North America, Western Europe and Australia, much less is known on the distribution of MRSA clones elsewhere.
S. Monecke   +17 more
semanticscholar   +1 more source

Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid [PDF]

open access: yes, 2017
BACKGROUND: Staphylococcal infection of the canine epidermis and hair follicle is amongst the commonest reasons for antimicrobial prescribing in small animal veterinary practice.
A Loeffler   +29 more
core   +5 more sources

In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).

open access: yesJournal of Antimicrobial Chemotherapy, 2021
BACKGROUND Current antimicrobial susceptibility/resistance data versus skin and soft tissue infection (SSTI) pathogens help to guide empirical treatment using topical antimicrobials.
G. Zhanel   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy